🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a partially randomized, open-label phase 1 study to evaluate the sa...
Status
Recruiting
Location
Bridge HIV, San Francisco Department of Public Health
Start Date
2025-03-17
Trial ID
NCT06796686
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Alabama CRS
Start Date
2020-01-13
Trial ID
NCT04177355
The goal of this clinical trial is to test 16055 NFL delta Gly4 Env protein...
Status
Active Not Recruiting
Location
Alabama CRS
Start Date
2024-03-15
Trial ID
NCT06332339
Treatments Being Tested
An Open-Label Study to Evaluate the Safety and Immunogenicity of 2 Doses of...
Status
Unknown
Location
The Amsterdam University Medical Centers
Start Date
2024-04-16
Trial ID
NCT05983874
Treatments Being Tested
This is a phase 1, first-in-human (FIH) trial for the combination of UVAX-1...
Status
Suspended
Location
Alabama CRS (#31788)
Start Date
2025-07-07
Trial ID
NCT06905275
Treatments Being Tested
This is an open-label Phase 1 study to examine the safety and immunogenicit...
Status
Completed
Location
The Hope Clinic of the Emory Vaccine Center CRS
Start Date
2023-01-23
Trial ID
NCT04915768
Treatments Being Tested
This is a multicenter controlled interventional trial. This phase 1 trial i...
Status
Active Not Recruiting
Location
Birmingham
Start Date
2024-01-03
Trial ID
NCT06006546
Treatments Being Tested
An Open-Label Study to Evaluate the Safety and Immunogenicity of 2 Doses of...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05863585
Treatments Being Tested
The clinical study is designed to evaluate the ability of two priming vacci...
Status
Completed
Location
Alabama CRS
Start Date
2022-08-22
Trial ID
NCT05471076
Treatments Being Tested
This is an open-label study to examine the safety and immunogenicity of syn...
Status
Completed
Location
Alabama CRS (Site ID: 31788)
Start Date
2023-04-10
Trial ID
NCT05781542
Treatments Being Tested